BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

62 related articles for article (PubMed ID: 28890347)

  • 1. High-resolution structure discloses the potential for allosteric regulation of mitogen-activated protein kinase kinase 7.
    Kinoshita T; Hashimoto T; Sogabe Y; Fukada H; Matsumoto T; Sawa M
    Biochem Biophys Res Commun; 2017 Nov; 493(1):313-317. PubMed ID: 28890347
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A crucial role of Cys218 in configuring an unprecedented auto-inhibition form of MAP2K7.
    Sogabe Y; Hashimoto T; Matsumoto T; Kirii Y; Sawa M; Kinoshita T
    Biochem Biophys Res Commun; 2016 Apr; 473(2):476-81. PubMed ID: 26987717
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 5Z-7-Oxozeaenol covalently binds to MAP2K7 at Cys218 in an unprecedented manner.
    Sogabe Y; Matsumoto T; Hashimoto T; Kirii Y; Sawa M; Kinoshita T
    Bioorg Med Chem Lett; 2015 Feb; 25(3):593-6. PubMed ID: 25529738
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structural basis for producing selective MAP2K7 inhibitors.
    Murakawa Y; Valter S; Barr H; London N; Kinoshita T
    Bioorg Med Chem Lett; 2020 Nov; 30(22):127546. PubMed ID: 32931911
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Seven cysteine-deficient mutants depict the interplay between thermal and chemical stabilities of individual cysteine residues in mitogen-activated protein kinase c-Jun N-terminal kinase 1.
    Nakaniwa T; Fukada H; Inoue T; Gouda M; Nakai R; Kirii Y; Adachi M; Tamada T; Segawa S; Kuroki R; Tada T; Kinoshita T
    Biochemistry; 2012 Oct; 51(42):8410-21. PubMed ID: 23020677
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Discovery and characterization of non-ATP site inhibitors of the mitogen activated protein (MAP) kinases.
    Comess KM; Sun C; Abad-Zapatero C; Goedken ER; Gum RJ; Borhani DW; Argiriadi M; Groebe DR; Jia Y; Clampit JE; Haasch DL; Smith HT; Wang S; Song D; Coen ML; Cloutier TE; Tang H; Cheng X; Quinn C; Liu B; Xin Z; Liu G; Fry EH; Stoll V; Ng TI; Banach D; Marcotte D; Burns DJ; Calderwood DJ; Hajduk PJ
    ACS Chem Biol; 2011 Mar; 6(3):234-44. PubMed ID: 21090814
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanisms for auto-inhibition and forced product release in glycine N-methyltransferase: crystal structures of wild-type, mutant R175K and S-adenosylhomocysteine-bound R175K enzymes.
    Huang Y; Komoto J; Konishi K; Takata Y; Ogawa H; Gomi T; Fujioka M; Takusagawa F
    J Mol Biol; 2000 Apr; 298(1):149-62. PubMed ID: 10756111
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exploring Molecular Mechanisms of Paradoxical Activation in the BRAF Kinase Dimers: Atomistic Simulations of Conformational Dynamics and Modeling of Allosteric Communication Networks and Signaling Pathways.
    Tse A; Verkhivker GM
    PLoS One; 2016; 11(11):e0166583. PubMed ID: 27861609
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structure and dynamics of the MKK7-JNK signaling complex.
    Kragelj J; Palencia A; Nanao MH; Maurin D; Bouvignies G; Blackledge M; Jensen MR
    Proc Natl Acad Sci U S A; 2015 Mar; 112(11):3409-14. PubMed ID: 25737554
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular dynamics simulation and free energy calculation studies of kinase inhibitors binding to active and inactive conformations of VEGFR-2.
    Wu X; Wan S; Wang G; Jin H; Li Z; Tian Y; Zhu Z; Zhang J
    J Mol Graph Model; 2015 Mar; 56():103-12. PubMed ID: 25594497
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel lipid binding site formed by the MAP kinase insert in p38 alpha.
    Diskin R; Engelberg D; Livnah O
    J Mol Biol; 2008 Jan; 375(1):70-9. PubMed ID: 17999933
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Crystal structures of MEK1 binary and ternary complexes with nucleotides and inhibitors.
    Fischmann TO; Smith CK; Mayhood TW; Myers JE; Reichert P; Mannarino A; Carr D; Zhu H; Wong J; Yang RS; Le HV; Madison VS
    Biochemistry; 2009 Mar; 48(12):2661-74. PubMed ID: 19161339
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DFGmodel: predicting protein kinase structures in inactive states for structure-based discovery of type-II inhibitors.
    Ung PM; Schlessinger A
    ACS Chem Biol; 2015 Jan; 10(1):269-78. PubMed ID: 25420233
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Converging evidence that sequence variations in the novel candidate gene MAP2K7 (MKK7) are functionally associated with schizophrenia.
    Winchester CL; Ohzeki H; Vouyiouklis DA; Thompson R; Penninger JM; Yamagami K; Norrie JD; Hunter R; Pratt JA; Morris BJ
    Hum Mol Genet; 2012 Nov; 21(22):4910-21. PubMed ID: 22899651
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cysteine residues in the C-terminal lobe of Src: their role in the suppression of the Src kinase.
    Oo ML; Senga T; Thant AA; Amin AR; Huang P; Mon NN; Hamaguchi M
    Oncogene; 2003 Mar; 22(9):1411-7. PubMed ID: 12618767
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Selectively targeting an inactive conformation of interleukin-2-inducible T-cell kinase by allosteric inhibitors.
    Han S; Czerwinski RM; Caspers NL; Limburg DC; Ding W; Wang H; Ohren JF; Rajamohan F; McLellan TJ; Unwalla R; Choi C; Parikh MD; Seth N; Edmonds J; Phillips C; Shakya S; Li X; Spaulding V; Hughes S; Cook A; Robinson C; Mathias JP; Navratilova I; Medley QG; Anderson DR; Kurumbail RG; Aulabaugh A
    Biochem J; 2014 Jun; 460(2):211-22. PubMed ID: 24593284
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular dynamics studies of the wild-type and double mutant HIV-1 integrase complexed with the 5CITEP inhibitor: mechanism for inhibition and drug resistance.
    Barreca ML; Lee KW; Chimirri A; Briggs JM
    Biophys J; 2003 Mar; 84(3):1450-63. PubMed ID: 12609852
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of a cysteine residue in the active site of ERK and the MAPKK family.
    Ohori M; Kinoshita T; Yoshimura S; Warizaya M; Nakajima H; Miyake H
    Biochem Biophys Res Commun; 2007 Feb; 353(3):633-7. PubMed ID: 17194451
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Substituting c-Jun N-terminal kinase-3 (JNK3) ATP-binding site amino acid residues with their p38 counterparts affects binding of JNK- and p38-selective inhibitors.
    Fricker M; Lograsso P; Ellis S; Wilkie N; Hunt P; Pollack SJ
    Arch Biochem Biophys; 2005 Jun; 438(2):195-205. PubMed ID: 15907786
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structure of human protein kinase C eta (PKCeta) C2 domain and identification of phosphorylation sites.
    Littler DR; Walker JR; She YM; Finerty PJ; Newman EM; Dhe-Paganon S
    Biochem Biophys Res Commun; 2006 Nov; 349(4):1182-9. PubMed ID: 16973127
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.